News and Events

Blog Post Filter

In a recent Select Science Editorial Article, Dr. Harald Messer, Gene Therapies Senior Scientist at Novartis, talks about the key considerations and challenges associated with developing biologically relevant cell-based assays that reflect mechanisms of action (MoA) and drug potency that represent ... Read more
Biopharmaceuticals, also known as biologics, have revolutionized the treatment of many human diseases in recent years. Immunologic conditions, diabetes, and some forms of cancer are now routinely treated with biopharmaceuticals. Biologics are large protein-based compounds that are developed from ... Read more
In a recent interview by Select Science, Heather Watson, Senior Manager in the Immunochemistry Department at Labcorp highlights how the industry is improving patient care by delivering innovative solutions that support faster and more cost-effective treatment.   Read more
Stimulation of Toll-like receptors (TLRs) to activate the innate immune system has been a legitimate therapeutic strategy for some years. Several TLRs, namely 3, 4, 7, 8, and 9, are validated targets for cancer, and pharmaceutical companies are actively developing TLR agonists and vaccine ... Read more